NPNatalia Ramírez Pedraza

Natalia Ramírez Pedraza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Natalia Ramírez Pedraza has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Perianal Fistula and Abscess: An Imaging Guide for Beginners

    by Natalia Ramírez Pedraza, Aarón Horeb Pérez Segovia, Juan Alberto Garay Mora, Kurt Techawatanaset, Andrew W. Bowman, Miguel Angel Cruz Marmolejo, Mónica Chapa Ibargüengoitia, Sofía Arizaga Ramírez, María Rebeca Arizaga Ramírez

    Perianal fistulas can be associated with significant morbidity, and knowledge of how they arise, how to image them, and their classification is paramount to ensure appropriate patient treatment.


  • Open Access

    Epicardial adipose tissue thickness is associated with increased COVID-19 severity and mortality

    by Roopa Mehta, Omar Yaxmehen Bello-Chavolla, Leonardo Mancillas-Adame, Marcela Rodriguez-Flores, Natalia Ramírez Pedraza, Bethsabel Rodríguez Encinas, Carolina Isabel Pérez Carrión, María Isabel Jasso Ávila, Jorge Carlos Valladares-García, Pablo Esteban Vanegas-Cedillo, et al.

    BACKGROUND Obesity, in particular, visceral adipose tissue has been linked to adverse COVID-19 outcomes. The amount of epicardial adipose tissue (EAT) may have relevant implications given its proximity to the heart and lungs. Here, we explored the role of EAT in increasing the risk for COVID-19 adverse outcomes. METHODS We included 748 patients with COVID-19 attending a reference centre in Mexico City. EAT thickness, sub-thoracic and pericardial fat were measured using thoracic CT scans. We explored the association of each thoracic adipose tissue compartment with critical COVID-19 and mortality according to the presence or absence of obesity. Mediation analyses evaluated the role of EAT in facilitating the effect of age, body mass index and cardiac troponin levels with adverse COVID-19 outcomes. RESULTS EAT thickness was associated with increased risk of COVID-19 mortality (HR 1.18, 95%CI 1.01-1.39) independent of age, gender, comorbid conditions and BMI. Increased EAT was associated with lower SpO2 and PaFi index and higher levels of cardiac troponins, D-dimer, C-reactive protein, and 4C severity score, independent of obesity. EAT mediated 13.1% (95%CI 3.67-28.0%) and 5.1% (95%CI 0.19-14.0%) of the effect of age and 19.4% (95%CI 4.67-63.0%) and 12.8% (95%CI 0.03-46.0%) of the effect of BMI on requirement for intubation and mortality, respectively. EAT also mediated the effect of increased cardiac troponins on myocardial infarction during COVID-19. CONCLUSION EAT is an independent risk factor for severe COVID-19 and mortality independent of obesity. EAT partly mediates the effect of age and BMI and increased cardiac troponins on adverse COVID-19 outcomes.


  • Open Access

    Serum Vitamin D levels are associated with increased COVID-19 severity and mortality independent of whole-body and visceral adiposity

    by Pablo Esteban Vanegas-Cedillo, Omar Yaxmehen Bello-Chavolla, Natalia Ramírez-Pedraza, Bethsabel Rodríguez Encinas, Carolina Isabel Pérez Carrión, María Isabel Jasso-Ávila, Jorge Carlos Valladares-García, Diana Hernández-Juárez, Arsenio Vargas-Vázquez, Neftali Eduardo Antonio-Villa, et al.

    INTRODUCTION Coronavirus disease (COVID-19) is a global pandemic. Vitamin D (25-OHD) deficiency has been associated with susceptibility to infectious disease. In this study, the association between COVID-19 outcomes and 25-OHD levels in patients attending a COVID-19 reference center in Mexico City are examined. METHODS Consecutive patients with confirmed COVID-19 were evaluated. All patients underwent clinical evaluation (including outcomes), laboratory measurements (including 25-OHD) and a thoracic computerized tomography (including the measurement of epicardial fat thickness). Low vitamin D was defined as levels RESULTS Of the 551 patients included, low 25-OHD levels were present in 45.6% and severely low levels in 10.9%. Severely low 25-OHD levels were associated with mortality (HR 2.11, 95%CI 1.24-3.58, p=0.006) but not with critical COVID-19 (OR 0.97, 95%CI 0.94-0.99, p=0.042), adjusted for age, sex, body-mass index and epicardial fat. Using model-based causal mediation analyses the increased risk of COVID-19 mortality conferred by 25-OHD levels was partly mediated by its effect on D-dimer and cardiac ultrasensitive troponins. Notably, increased risk of COVID-19 mortality conferred by low vitamin D levels was independent of BMI and epicardial fat. CONCLUSION Vitamin D deficiency (≤12ng/mL or <30nmol/L), is independently associated with COVID-19 mortality after adjustment for visceral fat (epicardial fat thickness). Low 25-OHD may contribute to a pro-inflammatory and pro-thrombotic state, increasing the risk for adverse COVID-19 outcomes.